Web12 de dez. de 2024 · Call your doctor or get medical help if any of these side effects or any other side effects bother you or do not go away: Constipation, diarrhea, stomach pain, … Web18 de nov. de 2024 · In fact, it has been proven that cryotherapy during high-dose melphalan administration effectively reduces incidence and severity of OM in patients undergoing AHSCT 8,11.
Cryotherapy reduces oral mucositis and febrile episodes in …
WebHigh-dose melphalan (MEL) is the standard therapy for autologous stem cell transplantation (ASCT) in multiple myeloma (MM), although the optimal conditioning regimen remains yet to be identified. Thiotepa (THIO) appears to be a potentially effective option, with broad-spectrum antitumor efficacy that can be added to myeloablative multiagent … Web18 de abr. de 2011 · High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease. Bone Marrow Transplant 2008; 42 : 405–412. Article CAS Google Scholar rcb scoring breast
A Phase I Trial of High-Dose Lenalidomide and Melphalan as ... - PubMed
WebAutologous stem cell transplantation (ASCT) conditioned with high-dose chemotherapy has long been established as the standard of care for eligible patients with newly diagnosed multiple myeloma. Despite recent therapeutic advances, high-dose melphalan (HDM) remains the chemotherapy regimen of choice … WebAn overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis Bone Marrow Transplant. 2001 Oct;28 ... This … Web5 de nov. de 2024 · We recently shown that high-dose melphalan (HDM) followed by autologous stem cell transplant (ASCT) as first line therapy in young (<66 yrs) multiple ... (<66 yrs) multiple myeloma (MM) patients significantly improves progression-free survival (IFM/DFCI 2009 study). However, the impact of alkylating agent melphalan inducing N ... rcb schedule 2022